Survey Shows That Almost Four Out of Ten People with Diabetes Are Not Testing As They Should (1)

Roche Diagnostics ACCU-CHEK(R) Aviva blood glucose testing system

addresses their needs and can help them be healthy in the New Year

Dec 20, 2005, 00:00 ET from Roche Diagnostics

    INDIANAPOLIS, Dec. 20 /PRNewswire/ -- Testing blood sugar levels is one of
 the most important things that people with diabetes can do to help manage
 their disease and live a healthy lifestyle.  However, an Omnibus survey of
 1,002 adults with type 1 and type 2 diabetes indicates that almost 4 out of 10
 do not test as often as their doctors recommend.  Respondents cited having to
 reprick (48%) and painful testing (43%) as the most commonly encountered
 problems while testing blood glucose levels.(1)
     Based on these national survey results, people with diabetes may consider
 a New Year's commitment to better managing their diabetes by testing their
 blood glucose levels more often in order to stay healthy.  For example, the
 ACCU-CHEK Aviva system is a blood glucose management tool that addresses their
 needs and can help them be healthy in the New Year.  It helps alleviate
 repricking and eases painful testing.
     "There is no substitute for blood sugar monitoring. Testing is the best
 measure by which we can accurately determine the adequacy of our patients'
 blood sugar control," said Dr. Henry Rodriguez, Assistant Professor of
 Pediatrics, Indiana University School of Medicine, and Director of the
 Pediatric Diabetes Clinical Program, James Whitcomb Riley Hospital for
 Children.  "Products that can help increase testing frequency by taking away
 their frustrations are very important.  It can help people with diabetes live
 a healthier lifestyle and greatly enhance their ability to improve management
 of their diabetes."
     According to the Omnibus survey, respondents listed the top five barriers
 to testing(1):
     1.  Having to reprick
     2.  Painful testing
     3.  Wondering if the test result is really accurate
     4.  Difficulty drawing a large enough sample of blood
     5.  Having to retest due to an error message
     The ACCU-CHEK Aviva system helps to address each of these needs.  A wide
 mouth on the test strip quickly pulls in the small blood sample (0.6
 microliter) and is designed to fill the very first time.  The test strips are
 larger and wider than other leading systems, making them easier to handle for
 patients of all ages.
     Another finding from the Omnibus survey was that 95% of respondents
 indicated they would switch brands if they could find a meter system that
 would reduce the pain of testing(1) (painful testing was listed as the second
 of the top five barriers to testing).  In addition to helping avoid painful
 repricking due to unsuccessful tests or error messages, the system also
 includes the ACCU-CHEK Multiclix lancet device, which has a preloaded six-
 lancet drum, a patented cam-driven design, 11 different depth settings and
 supports alternate site testing.  The ACCU-CHEK Multiclix lancet device has
 been proven the least painful lancing option(2) and eliminates the need for
 patients to see or handle individual lancets.
     "People with diabetes need products that meet their specific needs and
 ensure confidence," said Don Dumoulin, Senior Vice President, U.S. Diabetes
 Care, Roche Diagnostics.  "Through our research, we've found that the hassle
 and pain of retesting are barriers to people testing as often as they should.
 The ACCU-CHEK Aviva system and ACCU-CHEK Multiclix lancet device are solutions
 to their concerns and help them test right the first time.  During this time
 of year, people often make New Year's pledges about their health, and this is
 a great product to help people test as they should."
     The Omnibus national survey also shows that patients have a desire to have
 integrated solutions that help them collect, analyze and act to help them
 manage their diabetes more easily, including:
     *  More than four in ten said they would be much more likely to buy a
 company's products if the company offered meters, pumps and other products
 that work together to help manage diabetes (46%) and if it provided tools that
 make it easier to share test results with their doctors (45%)(1).
     *  More than half of insulin users (and 62% of those who test four or more
 times a day) said they would be much more likely to buy a company's products
 if the company offered products and services to help them collect relevant
 information, analyze and act on it all for better self-management of
     The ACCU-CHEK Aviva blood glucose system was developed in response to
 extensive market research in the United States and Europe.  As a result, it
 provides users with features most important to them and helps them test right
 the first time, allowing them to avoid the pain of retesting.  During
 research, 97% of consumers dosed the ACCU-CHEK Aviva test strip successfully
 on the first attempt.(3)  In a consumer study, the ACCU-CHEK Multiclix lancet
 device was shown to be less painful, easier to use and quicker than the
 leading competitive lancing systems.(2)
     A total of 1,002 insulin users completed the Omnibus survey July 14-19,
 2005.  The sample, selected from Synovate's online Consumer Opinion Panel, was
 drawn from 3,400 households.  Results for the total sample are accurate to
 within plus or minus 3%.
     For more information please contact:
     Lori LeRoy
     Roche Diagnostics
     (1) Synovate's online Consumer Opinion Panel, "Barriers to Blood Glucose
 Testing".  Data on file.
     (2) Koubek, R.J., "Glucose Monitoring System Design Reduces Barriers to
 Testing," ACCU-CHEK Aviva system and ACCU-CHEK Multiclix lancet device human
 factors white paper, 2005.
     (3) ACCU-CHEK Aviva Evaluation Report. Data on file.
 SOFTCLIX and ACCU-CHEK COMPASS are trademarks of Roche.

SOURCE Roche Diagnostics